{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Niaspan&page=2", "query": { "intervention": "Niaspan", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Niaspan&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T02:53:47.742Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00630877", "title": "Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "Niacin extended-release (NER)", "type": "DRUG" }, { "name": "Niacin extended-release (NER) placebo", "type": "DRUG" }, { "name": "Aspirin (ASA)", "type": "DRUG" }, { "name": "Aspirin (ASA) placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 276, "start_date": "2008-02", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2009-10-09", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Anaheim, California • Walnut Creek, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Brooksville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00630877" }, { "nct_id": "NCT06175403", "title": "A Study of Niacin Regulation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Excessive Weight Gain" ], "interventions": [ { "name": "Niacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 32, "start_date": "2024-01-01", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06175403" }, { "nct_id": "NCT00071266", "title": "The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Intermittent Claudication", "Peripheral Vascular Disease" ], "interventions": [ { "name": "Niacin Extended Release and Lovastatin Tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kos Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 870, "start_date": "2003-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2006-11-02", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Palo Alto, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071266" }, { "nct_id": "NCT00397657", "title": "Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "extended release niacin", "type": "DRUG" }, { "name": "ezetimibe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Walter Reed Army Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 400, "start_date": "2006-11", "completion_date": "2009-10", "has_results": false, "last_update_posted_date": "2009-06-17", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Takoma Park, Maryland", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Takoma Park", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00397657" }, { "nct_id": "NCT01085981", "title": "Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Female Sexual Dysfunction" ], "interventions": [ { "name": "arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%", "type": "DRUG" }, { "name": "Topical study cream", "type": "DRUG" }, { "name": "GRAS cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "East Suburban Ob Gyn", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "25 Years to 60 Years · Female only" }, "enrollment_count": 30, "start_date": "2010-04", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-03-12", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 1, "location_summary": "Monroeville, Pennsylvania", "locations": [ { "city": "Monroeville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01085981" }, { "nct_id": "NCT00903617", "title": "Study to Test GSK256073 in Patients With Dyslipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidaemias", "Dyslipidemias" ], "interventions": [ { "name": "GSK256073", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Niaspan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2009-06-15", "completion_date": "2010-02-16", "has_results": true, "last_update_posted_date": "2019-12-05", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 11, "location_summary": "Pembroke Pines, Florida • Indianapolis, Indiana • Louisville, Kentucky + 8 more", "locations": [ { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Auburn", "state": "Maine" }, { "city": "Brooklyn Center", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00903617" }, { "nct_id": "NCT01129258", "title": "Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Glucose Metabolism Disorders" ], "interventions": [ { "name": "PF-04991532", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 110, "start_date": "2010-06", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2011-03-09", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 4, "location_summary": "Chula Vista, California • Fountain Valley, California • Miami, Florida + 1 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129258" }, { "nct_id": "NCT00715273", "title": "Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Carotid Artery Diseases", "Atherosclerosis" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Niacin", "type": "DRUG" }, { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo Niacin", "type": "DRUG" }, { "name": "Placebo Colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 217, "start_date": "2001-05-01", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2022-06-07", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 4, "location_summary": "Los Angeles, California • Boise, Idaho • Seattle, Washington + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boise", "state": "Idaho" }, { "city": "Seattle", "state": "Washington" }, { "city": "Yakima", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00715273" }, { "nct_id": "NCT00687076", "title": "Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Peripheral Arterial Disease" ], "interventions": [ { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Niaspan", "type": "DRUG" }, { "name": "Statin therapy", "type": "DRUG" }, { "name": "Standard care", "type": "BEHAVIORAL" }, { "name": "Aspirin", "type": "DRUG" }, { "name": "Clopidogrel", "type": "DRUG" }, { "name": "Placebo Niaspan", "type": "DRUG" }, { "name": "Placebo Ezetimibe", "type": "DRUG" }, { "name": "Percutaneous transluminal angioplasty (PTA)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 102, "start_date": "2004-04", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2020-02-06", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00687076" }, { "nct_id": "NCT06019858", "title": "A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Energy", "Fatigue", "Mood", "Weight Loss", "Cognition" ], "interventions": [ { "name": "Vitamin Energy Shot", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Vitamin Energy®", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-06-21", "completion_date": "2023-07-20", "has_results": false, "last_update_posted_date": "2023-08-31", "last_synced_at": "2026-09-26T02:53:47.742Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06019858" } ] }